<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A recent study has shown that <z:mp ids='MP_0001261'>obese</z:mp> patients with newly diagnosed type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> who lose 10% of their body weight are more likely to achieve glycaemic and blood pressure targets, despite weight regain </plain></SENT>
<SENT sid="1" pm="."><plain>A well-established non-surgical method for achieving <z:hpo ids='HP_0001824'>weight loss</z:hpo> &gt;or=10% within 3 months is the use of very-low-calorie diets (VLCDs) </plain></SENT>
<SENT sid="2" pm="."><plain>In patients with <z:mp ids='MP_0002055'>diabetes</z:mp>, VLCDs are associated with rapid improvement in glycaemia and <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>The present review analyses the evidence from available trials on the effects of VLCDs on body weight, glycaemic control and complications, and their potential for clinical use in <z:mp ids='MP_0002055'>diabetes</z:mp> management </plain></SENT>
</text></document>